Real-time enrollment status for this thrombotic thrombocytopenic purpura clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:37 PM UTC
| NCT Number | NCT01257269 |
| Recruiting Status | Recruiting |
| Condition | Thrombotic Thrombocytopenic Purpura |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Last Updated on CT.gov | October 11, 2023 (Oct 11, 2023) |
As of July 17, 2026: Clinical trial NCT01257269 is currently recruiting participants. This clinical trial study for thrombotic thrombocytopenic purpura is actively seeking new participants at 1 location across the United States. The study is sponsored by Insel Gruppe AG, University Hospital Bern. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01257269 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01257269 was last updated Oct 11, 2023 (October 11, 2023). HelloStudys verifies this status automatically.